C3 Jian Names Todd Patrick CEO

Todd Patrick, the former president of Vancouver, BC and Bothell, WA-based ID Biomedical, has been named the new CEO of Los Angeles-based C3 Jian. The company is developing selective antibacterial and antifungal treatments, as well as drugs for disorders of mineralization, and reversing hair loss. Patrick, the chairman of the board at the Seattle Biomedical Research Institute, was part of the executive team that sold ID Biomedical for $1.5 billion to GlaxoSmithKline in 2005.

Trending on Xconomy